Results 71 to 80 of about 13,867 (142)

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma. [PDF]

Sci Adv
Han JZR, Phimmachanh M, Hastings JF, Leong KH, Ng BH, Ni J, Fontaine-Titley A, Cadell AL, O'Donnell YE, Clearwater M, Kamili A, Haber M, Norris M, Timpson P, Trahair TN, Fletcher JI, Fey D, Kolch W, Latham SL, Croucher DR.   +19 more
europepmc   +1 more source

Quantitative high-throughput screening identifies small-molecule modulators of Wnt/β-catenin signaling. [PDF]

Front Pharmacol
Chen X, Yang S, Sakamuru S, Sukhawanit C, Wood S, Ooka M, Huang R, Xia M.   +7 more
europepmc   +1 more source

Cost-Effectiveness of Tarlatamab in the Second-Line Treatment of Refractory Small Cell Lung Cancer From a US Perspective. [PDF]

Clin Med Insights Oncol
Zheng H, Wen F, Wu B.
europepmc   +1 more source

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial. [PDF]

Neurooncol Adv
Ozer BH, Cohen AL, Colman H, Penas-Prado M, de Groot J, Loghin ME, Pan E, Raizer JJ, Kumthekar P, Fink KL, Walbert T, Merrell RT, Groves MD, Ahluwalia MS, Wu J, Burton EC, Vera E, Mendoza T, Grajkowska E, Wall K, Reyes J, Yuan Y, Armstrong TS, Gilbert MR.   +23 more
europepmc   +1 more source

Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma. [PDF]

Mol Ther Oncol
Kelk J, Rozanska A, Sotiriadou E, Astley D, Hussain R, Unsworth A, Gangar A, Robinson A, Queen R, Coxhead J, Steel DH, Armstrong L, Parulekar M, Hardcastle I, Veal GJ, Lako M.   +15 more
europepmc   +1 more source

SGSS05-NS3, a covalent SETD8 inhibitor that activates p53 pathway in neuroblastoma. [PDF]

J Exp Clin Cancer Res
Liu Z, Bagchi S, Yan C, Hu Y, Blum G, Ma A, Jin J, Luo M, Di Bella S, Verona F, Appella E, Giannini G, Thiele CJ, Veschi V.   +13 more
europepmc   +1 more source

Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform. [PDF]

J Cheminform
Xu S, Hu Y, Mangione W, Van Norden M, Elefteriou K, Falls Z, Samudrala R.   +6 more
europepmc   +1 more source

Integrated computational screening of FDA-approved anticancer drugs as novel HPV-16 E6 inhibitors in cervical cancer. [PDF]

Sci Rep
Ahmadi M, Yoosefian M.
europepmc   +1 more source

Comparison of the Efficacy of 35 Anticancer Drugs According to Genomic Profiling and Biological Characteristics of 14 Gastric Cancer Cell Lines. [PDF]

Int J Mol Sci
Sohn SH, Sul HJ, Kim BJ, Zang DY.
europepmc   +1 more source

Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents and DNA repair genes. [PDF]

NAR Cancer
Heer CD, Elia JL, Menon V, Johnson SS, Arbelaez SR, Friedman S, Lopez-Giraldez F, Sundaram RK, Herzon SB, Bindra RS, Gueble SE.   +10 more
europepmc   +1 more source